Immunization with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) according to different schedules in infants in South Africa: a phase III trial

Immunization with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) according to different schedules in infants in South Africa: a phase III trial

Background: Limited clinical data exists to assess differences between various infant pneumococcal conjugate vaccine schedules. In this trial, we evaluated immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) administered using 3 diff...

Full description

Bibliographic Details
Main Authors: Shabir A Madhi, Anthonet Koen, Lisa Jose, Marta Moreira, Nadia van Niekerk, Clare Cutland, Nancy François, Javier Ruiz-Guiñazú, Juan Pablo Yarzabal, Dorota Borys, Lode Schuerman
Format: Article
Language:English
Published: Taylor & Francis Group 2017-06-01
Series:Expert Review of Vaccines
Subjects:
expanded program on immunization
immunogenicity
pneumococcal conjugate vaccine
safety
vaccination schedule
infants
Online Access:http://dx.doi.org/10.1080/14760584.2017.1321990

Internet

http://dx.doi.org/10.1080/14760584.2017.1321990

Similar Items